Skip to main navigation Skip to search Skip to main content

Point of care Tuberculosis diagnostics using a novel diagnostic test without a need for electricity or laboratory facilities

  • Morrison, Valerie (Participant)
  • Hartsuiker, Edgar (Participant)
  • Algar, Katherine (Participant)

    Impact: Health/Quality of life

    Description of impact

    The newly developed test, based on proprietary lipid technology, will allow affordable testing for Tuberculosis at the point of care without a need for electricity or access to a specialist laboratory. Beneficiaries will be Tuberculosis patients (mainly in underdeveloped countries).

    Beneficiaries and reach of impact

    Beneficiaries will be Tuberculosis patients (mainly in underdeveloped countries).
    Impact statusOngoing
    Category of impactHealth/Quality of life